Caitlin Koury is named as a lobbyist on federal disclosure filings for 60 clients through Checkmate Government Relations and 2 other registrants. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs and Science/Technology.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| QUALTRICS INTERNATIONAL INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Science/Technology |
| SIMMONS FOOD | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Trade (domestic/foreign), Health Issues |
| VERADERMICS, INCORPORATED | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Pharmacy, Health Issues |
| ANDROMEDA HEALTH CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| SENPHONIX, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Science/Technology, Medicare/Medicaid, Health Issues |
| CRESCEL LLC | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| SAS INSTITUTE INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Science/Technology |
| CAPRICOR THERAPEUTICS | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| MOLECULIGHT, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| PHARMAESSENTIA USA CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| REPLIMUNE, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| THE ARBITRUS CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| BLINK HEALTH, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| BLACKSTONE ADMINISTRATIVE SERVICES PARTNERSHIP L.P. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| BIOHAVEN LTD. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues |
| SYDNEXIS, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| ABBVIE INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| INCYTE CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medicare/Medicaid |
| HILLFIELD LLC | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Tobacco, Health Issues |
| SESH+ PRODUCTS U.S., INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Tobacco, Health Issues |
| NEPHRON NITRILE D/B/A AMERICAN ARMOR GLOVES | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Defense, Medical/Disease Research/Clinical Labs |
| PROJECT FOOD BOX | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Agriculture, Health Issues, Food Industry (safety, labeling, etc.) |
| STOP GAS STATION HEROIN LLC | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Alcohol and Drug Abuse |
| STOLL KEENON ODGEN GOVT. RELS. LLC (ON BEHALF OF KY MEDICAL SERVS FOUND.) | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| PHIBRO ANIMAL HEALTH CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Animals, Science/Technology |
| BAPTIST HEALTH SOUTH FLORIDA | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| RTI INTERNATIONAL | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| FRANCISCAN MISSIONARIES OF OUR LADY HEALTH SYSTEM | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| REGENERON PHARMACEUTICALS INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| ELI LILLY AND COMPANY | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Trade (domestic/foreign), Health Issues |
| SANOFI US SERVICES INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| GSK | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Pharmacy, Health Issues |
| PATIENTS TO FIGHT CHRONIC DISEASE | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| NOVO NORDISK, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2026 | Health Issues |
| MAKO MEDICAL LABORATORIES LLC | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Medical/Disease Research/Clinical Labs |
| SPORTS BETTING ALLIANCE | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Gaming/Gambling/Casino, Sports/Athletics |
| SALESFORCE, INC. | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Computer Industry, Government Issues |
| THE GEO GROUP, INC. | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Law Enforcement/Crime/Criminal Justice, Homeland Security |
| SUMMIT SD, LLC | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Health Issues, Manufacturing |
| KIDNEY CARE ACCESS COLAITION, INC. | CHECKMATE GOVERNMENT RELATIONS | Q2 2026 | Health Issues |
| REDCAP LLC | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Health Issues |
| AMERICAN HEALTHCARE SYSTEMS | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Taxation/Internal Revenue Code, Health Issues |
| SAMSARA, MULTISTATE ASSOCIATES, LLC | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Transportation |
| THE CATAWBA NATION | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Indian/Native American Affairs |
| PROMISE NETWORK INC. | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Health Issues |
| SYNGENTA CORPORATION | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Agriculture |
| COTTAGE HEALTH HOSPITALS | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Health Issues |
| PATIENTSACT | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Health Issues |
| HEALTH EQUALITY CAMPAIGN | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Medicare/Medicaid |
| COQUILLE INDIAN TRIBE | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Indian/Native American Affairs |
| VANTIVE HEALTH LLC | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| ALP SUPPLY CO. LLC | CHECKMATE GOVERNMENT RELATIONS | Q1 2026 | Tobacco, Taxation/Internal Revenue Code |
| ALPEK POLYESTER USA, LLC | CHECKMATE GOVERNMENT RELATIONS | Q4 2025 | Tariff (miscellaneous tariff bills), Chemicals/Chemical Industry |
| NEURONETICS, INC. | CHECKMATE GOVERNMENT RELATIONS | Q4 2025 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| AMERICAN TURKISH BUSINESS ROUNDTABLE | CHECKMATE GOVERNMENT RELATIONS | Q3 2025 | Economics/Economic Development |
| HANESBRAND INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2025 | Tariff (miscellaneous tariff bills), Manufacturing |
| JUUL LABS, INC. | CHECKMATE GOVERNMENT RELATIONS | Q3 2025 | Tobacco |
| NEPA WHOLESALE, INC. | CHECKMATE GOVERNMENT RELATIONS | Q2 2025 | Tobacco |
| HEALTH EQUALITY CAMPAIGN | HEALTH EQUALITY CAMPAIGN INC. | Q2 2025 | Health Issues |
Showing the 60 most recent of 61 engagements.
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 51 | 1 |
| 2025 | 36 | 2 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Caitlin Koury. See the Capitol Clarity rankings and method.